Weinstein v. McClendon
757 F.3d 1110
10th Cir.2014Background
- Plaintiffs filed a consolidated securities-class action on behalf of purchasers of Chesapeake Energy stock (Apr 30, 2009–May 11, 2012), alleging misleading statements and omissions about two corporate programs: Volumetric Production Payments (VPPs) and the Founder Well Participation Program (FWPP).
- VPPs: Chesapeake raised >$6.3 billion by selling future production; plaintiffs allege defendants failed to disclose ~ $1.4 billion of future production costs required to deliver that gas, masking increased corporate liabilities.
- FWPP: CEO Aubrey McClendon elected to participate in nearly all new wells; plaintiffs allege the program incentivized aggressive land acquisition, created conflicts of interest, and defendants misrepresented that the FWPP fully aligned McClendon’s interests with Chesapeake’s.
- Plaintiffs also allege defendants omitted that McClendon financed his FWPP interests with non-recourse loans from lenders who did business with Chesapeake, removing his personal risk and undermining alignment with the company.
- Plaintiffs claim these statements and omissions inflated stock price, and that disclosure of the true facts caused a ~60% drop. The district court dismissed for failure to plead scienter with particularity under the PSLRA; this appeal followed.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether complaint pleads false/misleading statements or omissions under §10(b) and PSLRA specificity rules | VPPs and FWPP statements/omissions misled investors about liabilities and alignment; plaintiffs identified specific statements and omissions | Alleged statements were vague/subjective and plaintiffs failed to plead particularized facts showing defendants knew non-disclosure would likely mislead investors | Court assumed the alleged misstatements/omissions but ruled plaintiffs failed to plead scienter with particularity; dismissal affirmed |
| Whether plaintiffs pleaded scienter (intent to defraud or recklessness) with particularity | Importance of VPP/FWPP to Chesapeake’s debt strategy and post-disclosure price drop support a cogent inference of scienter | Plaintiffs only allege knowledge of potentially material facts; no concrete allegations showing intent or recklessness; alternative nonculpable inferences exist | Pleading did not raise a cogent and compelling inference of scienter at least as strong as nonculpable inferences; scienter not established |
| Whether alleged omissions were so obviously material that defendants must have known non-disclosure would mislead investors | VPP production costs and McClendon financing were plainly material; failure to disclose is actionable | Materiality alone (later established) does not prove defendants knew non-disclosure would likely mislead; need stronger particularized facts | Plaintiffs failed to show defendants knew nondisclosure would likely mislead; recklessness not pleaded adequately |
| Whether Matrixx precedent supports finding scienter here | Matrixx shows that concealment of objective, specific adverse information + affirmative denials can support scienter | Matrixx involved much stronger, specific affirmative steps to discredit reports; the present allegations are vaguer and less probative of intent | Court distinguished Matrixx and found it inapposite; Matrixx supports scienter only where affirmative, specific misleading acts are alleged |
Key Cases Cited
- City of Philadelphia v. Fleming Cos., 264 F.3d 1245 (10th Cir. 2001) (PSLRA heightened pleading and scienter standards explained)
- Greebel v. FTP Software, Inc., 194 F.3d 185 (1st Cir. 1999) (context on PSLRA purpose and pleading specificity)
- In re Level 3 Communications, Inc. Securities Litigation, 667 F.3d 1331 (10th Cir. 2012) (collective-allegations must paint a sufficient portrait of scienter)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (2007) (courts must weigh competing inferences and require a cogent and compelling inference of scienter)
- Matrixx Initiatives, Inc. v. Siracusano, 131 S. Ct. 1309 (2011) (affirmative discrediting of specific adverse reports can support a strong inference of scienter)